Is osteosarcoma cancer?

Osteosarcoma is also a malignant tumor. It is a type of cancer. In fact, it is what we often call bone cancer. It may be more common among teenagers. After getting bone cancer, it will cause greater harm to the patient. It may not be obvious in the early stage, but as the disease progresses, the patient will suffer some more serious harm, and even metastasis may occur, which may be transferred to the lungs. When osteosarcoma occurs, the patient may be prone to fractures, and may also have symptoms such as muscle atrophy, so osteosarcoma is a type of cancer.

How long can you live after osteosarcoma surgery?

With the advancement of neoadjuvant chemotherapy and combined surgical treatment, as well as the rapid development of early diagnosis and chemotherapy in recent years, the survival rate of osteosarcoma has been significantly improved. The 5-year survival rate has now reached over 50%, and some patients have even lived for 10 or 20 years. Therefore, the survival rate of osteosarcoma has been greatly improved, and the quality of life has also been greatly improved.

Uterine stromal tumor survival rate

Low-grade malignant tumors account for about 80%, with mild clinical symptoms and slow progression of the disease. The impact on physical health is not very serious. As long as it is discovered early and treated in time, the recurrence rate after surgery is relatively low, and the 5-year survival rate is relatively high. If it is a highly malignant tumor, the disease progresses quickly, it is easy to invade and metastasize, and the prognosis is poor. The chance of recurrence after surgery is very high, and the 5-year survival rate is relatively low at around 20%-30%. Due to the different stages of the lesions when the lesions are discovered and the different personal constitutions, the follow-up treatment and nursing measures after surgery also have a very obvious impact on the patient's prognosis. After surgery, a light, easily digestible, high-protein, and high-vitamin diet is the main treatment. Uterine stromal sarcoma is a malignant tumor derived from endometrial stromal cells. It can be divided into low-grade malignant tumors and highly malignant tumors. It can be manifested as irregular vaginal bleeding, increased menstruation, vaginal discharge, anemia, lower abdominal pain, etc.